MAZE THERAPEUTICS INC (MAZE) Earnings History & Surprises

NASDAQ:MAZEUS5787841007

Current stock price

33.87 USD
-15.13 (-30.88%)
Last:

MAZE Earnings overview

Past quarterly earnings results for MAZE THERAPEUTICS INC (MAZE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Apr 6, 2026
Period
Q4 / 2025
EPS Estimate
-$0.72
Revenue Estimate

Last Reported

Most Recent
Release Date
Nov 6, 2025
Period
Q3 / 2025
EPS Reported
-$0.66
EPS Surprise
8.68%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2025 -0.66 -0.72 8.68% - - -100.00%
Q2 2025 -0.77 -0.87 11.81% - 2.125M -100.00% -100.00%
Q1 2025 -1.15 -0.77 -49.66% - - -
Q4 2024 -18.32 0.46 -4,091.29% - - -
Q3 2024 - - 2.5M - -
Q2 2024 - - 165M - -
Q4 2023 - - - -
Q3 2023 - - - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

MAZE EPS Q2Q GrowthMAZE EPS Q2Q GrowthEPS Q2Q Growth Q4/25 Q1/26 Q2/26 Q3/26 Q4/26 0 20 -20 40 60 80

Revenue Historical Q2Q growth and Acceleration

MAZE Revenue Q2Q GrowthMAZE Revenue Q2Q GrowthRevenue Q2Q Growth Q2/25 Q3/25 -20 -40 -60 -80

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-1,030.11%
Max EPS beat (4)
11.81%
Min EPS beat (4)
-4,091.29%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, MAZE has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, MAZE reported -1030.1% below the EPS estimates on average.

MAZE THERAPEUTICS INC / MAZE Earnings FAQ

When did MAZE THERAPEUTICS INC (MAZE) report earnings last quarter?

MAZE THERAPEUTICS INC (MAZE) last reported earnings on 11/6/2025.

Did MAZE THERAPEUTICS INC (MAZE) beat earnings estimates last quarter?

MAZE THERAPEUTICS INC (MAZE) beat EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often MAZE THERAPEUTICS INC beats earnings estimates?

In the last 4 quarters, MAZE THERAPEUTICS INC (MAZE) has beaten EPS estimates in 2 out of 4 releases.